Clinical Research Directory
Browse clinical research sites, groups, and studies.
Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®
Sponsor: CivaTech Oncology
Summary
This patient study will determine the safety and toxicity of a permanently implantable brachytherapy source - CivaSheet® - which is designed to deliver a therapeutic dose of low dose rate (LDR) radiation with polymer encased Palladium-103. CivaSheet will be implanted in sarcoma patients with disease presenting in the retroperitoneum, abdomen, pelvis and trunk.
Official title: Registry of Retroperitoneal, Abdominal, Pelvic and Truncal Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet® to Evaluate the Safety and Feasibility Over 5 Years
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2020-04-30
Completion Date
2030-04
Last Updated
2026-03-23
Healthy Volunteers
No
Conditions
Interventions
CivaSheet
Implanting CivaSheet radiation therapy device at the time of surgery to irradiate surgical margin potentially preventing local recurrence
Locations (1)
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States